Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone
✍ Scribed by C. H. Langeveld; M. P. van Waas; Dr. J. C. Stoof; W. Suianto; E. R. de Kloet; J. G. Wolbers; J. J. Heimans
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 842 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Dexamethasone is frequently used in the therapy of brain tumor patients. We investigated the effect of dexamethasone on the proliferation of three short‐term and four established human glioma cell lines in vitro, using a microculture tetrazolium assay to determine growth rates. In one short‐term culture and in one established cell line dexamethasone consistently stimulated the proliferation in concentration‐dependent way. The proliferation was maximally enhanced at a concentration of approximately 0.1 μM. In these two cell lines a relatively high level of glucocorticoid receptors was present, whereas low levels of glucocorticoid receptors were found in the other cell lines. In addition, we demonstrated that the stimulatory effects of dexamethasone on the proliferation of the glioma cell lines can be antagonized by the antiglucocorticoid RU38486. The results demonstrate unequivocally that the glucocorticoid receptor plays a role in the growth stimulating effect of dexamethasone.
📜 SIMILAR VOLUMES
Although marrow adipocytes and osteoblasts derive from a common bone marrow stromal cells (BMSCs), the mechanisms that underlie osteoporosis-associated bone loss and marrow adipogenesis during prolonged steroid treatment are unclear. We show in human BMSCs (hBMSCs) that glucocorticoid receptor (GR)
## Abstract Glucocorticoids (GCs) at physiological concentrations stimulate osteoprogenitor proliferation and differentiation in rat bone cell populations, and this is mediated in part by an increased response to insulin‐like growth factors (IGFs). Since IGF binding proteins (IGFBPs) modulate IGF a
Recombinant human interleukin-1 beta, a mediator of osteoblastic cell function, was found to regulate the expression of the cell adhesion receptors, integrins, on human osteosarcoma cells. Interleukin-1 beta (IL-1 beta) at picomolar concentrations, specifically elevated approximately six- to tenfold
## Malignant gliomas are characterized by an extensive invasion of tumor cells into the normal brain parenchyma. A substantial amount of data indicates that cell movement in general is regulated by specific interactions between extracellular matrix components and specific cell-surface receptors. I
The interaction of urokinase-type plasminogen activator (uPA) with its cell-surface receptor (uPAR) is implicated in diverse biological processes such as cell migration, tissue remodeling, and tumor cell invasion. Recent studies indicated that uPAR can act as an extracellular matrix receptor during